The menopause transition: signs, symptoms, and management options

N Santoro, C Roeca, BA Peters… - The Journal of Clinical …, 2021 - academic.oup.com
Context Menopause, the permanent cessation of menses, reflects oocyte depletion and loss
of gonadal steroids. It is preceded by a transition state, the perimenopause, which is …

Adrenal insufficiency

ES Husebye, SH Pearce, NP Krone, O Kämpe - The Lancet, 2021 - thelancet.com
Adrenal insufficiency can arise from a primary adrenal disorder, secondary to
adrenocorticotropic hormone deficiency, or by suppression of adrenocorticotropic hormone …

2016 IMS Recommendations on women's midlife health and menopause hormone therapy

RJ Baber, N Panay, A Fenton - Climacteric, 2016 - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline

M Fleseriu, IA Hashim, N Karavitaki… - The Journal of …, 2016 - academic.oup.com
Objective: To formulate clinical practice guidelines for hormonal replacement in
hypopituitarism in adults. Participants: The participants include an Endocrine Society …

[HTML][HTML] Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause

SD Sullivan, PM Sarrel, LM Nelson - Fertility and sterility, 2016 - Elsevier
Primary ovarian insufficiency (POI) is a rare but important cause of ovarian hormone
deficiency and infertility in women. In addition to causing infertility, POI is associated with …

Long-term health consequences of premature or early menopause and considerations for management

SS Faubion, CL Kuhle, LT Shuster, WA Rocca - Climacteric, 2015 - Taylor & Francis
Aim To review the current evidence concerning the long-term harmful effects of premature or
early menopause, and to discuss some of the clinical implications. Material and methods …

Revised global consensus statement on menopausal hormone therapy

TJ De Villiers, JE Hall, JV Pinkerton, SC Pérez, M Rees… - Maturitas, 2016 - Elsevier
Abstract The following Consensus Statement is endorsed by The International Menopause
Society, The North American Menopause Society, The Endocrine Society, The European …

International Society for the Study of Women's Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in …

SJ Parish, JA Simon, SR Davis, A Giraldi… - The journal of sexual …, 2021 - academic.oup.com
ABSTRACT Background The Global Consensus Position Statement on the Use of
Testosterone Therapy for Women (Global Position Statement) recommended testosterone …

Hormones and aging: an endocrine society scientific statement

AR Cappola, RJ Auchus… - The Journal of …, 2023 - academic.oup.com
Multiple changes occur across various endocrine systems as an individual ages. The
understanding of the factors that cause age-related changes and how they should be …

Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data

RM Islam, RJ Bell, S Green, MJ Page… - The lancet Diabetes & …, 2019 - thelancet.com
Background The benefits and risks of testosterone treatment for women with diminished
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …